President Trump is expected to nominate Heidi Overton, a top conservative policy aide, as the next commissioner of the Food and Drug Administration, according to multiple media reports.
Overton is currently the deputy director of the White House Domestic Policy Council and has played a key role in shaping a variety of health policies during Trump’s second term.
She has notably angered members of the Make America Healthy Again movement, which was created by anti-vaccine Health Secretary Robert F. Kennedy Jr.
Background and Experience
Overton has a medical degree from the University of New Mexico School of Medicine and earned a doctoral degree in clinical investigation from Johns Hopkins Bloomberg School of Public Health.
While at Johns Hopkins, she worked with Marty Makary, the previous FDA commissioner who was ousted by Trump amid a series of controversies.
Makary and his political appointees at the FDA sparked anger and criticism due to a string of dubious moves on drugs for rare diseases, frustrating patients and the pharmaceutical industry alike.
Policy Positions
Overton has written articles calling abortion “corrosive” to women and calling abortion pills “far more dangerous to women,” despite extensive data suggesting that abortion pills are extremely safe.
Experts note that they are safer than taking Viagra or getting a colonoscopy and significantly safer than giving birth.
Still, Overton’s position aligns with conservative efforts to get the FDA to restrict access to abortion pills.
As the nomination moves forward, Overton’s views on abortion and other health policies will face scrutiny from various groups, including public health advocates and the pharmaceutical industry.
Related: Microsoft to retire 25-year-old Windows tool
For women seeking access to abortion pills, the nomination could have significant implications for their healthcare options.
The FDA plays a critical role in regulating access to abortion pills, and Overton’s views on the matter could influence the agency’s decisions.
According to the report, Overton was a staunch defender of Makary during his time in the role, which may indicate her approach to similar controversies in the future.
Previous Roles
Prior to her current White House role, she worked on health policy for the America First Policy Institute, a conservative think tank previously helmed by Brooke Rollins, who now serves as Trump’s agriculture secretary.
They have been involved in various conservative policy initiatives, and her experience there may have shaped her views on health policy.
As the FDA commissioner, Overton would oversee the regulation of a wide range of products, including foods, drugs, and medical devices.
It is a significant responsibility.
The FDA commissioner role requires a deep understanding of the complex issues surrounding public health and the ability to make informed decisions that impact the lives of millions of people.
Given her background and experience, Overton is likely to bring a unique perspective to the role, one that will be shaped by her time at the White House and her work with the America First Policy Institute.
Her nomination is expected to be closely watched by various stakeholders, including public health advocates, the pharmaceutical industry, and women’s rights groups.